Novozymes A/S (OTCMKTS:NVZMY) Sees Significant Decrease in Short Interest

Novozymes A/S (OTCMKTS:NVZMY) was the recipient of a significant decrease in short interest in the month of February. As of February 27th, there was short interest totaling 4,463 shares, a decrease of 20.1% from the February 12th total of 5,586 shares. Based on an average daily trading volume, of 305,495 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company’s stock are short sold. Approximately 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 305,495 shares, the short-interest ratio is presently 0.0 days.

Novozymes A/S Stock Down 0.0%

Shares of Novozymes A/S stock opened at $54.50 on Tuesday. The company has a quick ratio of 1.00, a current ratio of 1.61 and a debt-to-equity ratio of 0.26. Novozymes A/S has a 52-week low of $53.50 and a 52-week high of $75.99. The company has a market capitalization of $22.59 billion, a P/E ratio of 38.93, a P/E/G ratio of 0.99 and a beta of 1.11. The company has a 50 day moving average of $61.00 and a 200 day moving average of $61.93.

Novozymes A/S (OTCMKTS:NVZMY) last released its quarterly earnings data on Wednesday, February 25th. The biotechnology company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.79 by ($0.44). Novozymes A/S had a return on equity of 6.38% and a net margin of 13.96%.The firm had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.22 billion. As a group, research analysts forecast that Novozymes A/S will post 1.82 EPS for the current fiscal year.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).